Quantcast
Home / Practice Areas / Business and Civil Practice / Glaxo settles marketing fraud charges for record $3 billion

Glaxo settles marketing fraud charges for record $3 billion

GlaxoSmithKline has agreed to plead guilty and pay $3 billion to resolve charges that the pharmaceutical giant fraudulently marketed the prescription drugs Paxil, Wellbutrin and Avandia, the U.S. Justice Department has announced.